Paper26318836
Safety and efficacy of abobotulinumtoxinA for hemiparesis in adults with upper limb spasticity after stroke or traumatic brain injury: a double-blind randomised controlled trial.
Gracies JM and 17 others. Lancet Neurol, 2015. Cited by 160 papers, by iCite.
Cite this record
ConductScience Library. Safety and efficacy of abobotulinumtoxinA for hemiparesis in adults with upper limb spasticity after stroke or traumatic brain injury: a double-blind randomised controlled trial. Papers, record 26318836. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/26318836
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Safety and efficacy of abobotulinumtoxinA for hemiparesis in adults with upper limb spasticity after stroke or traumatic brain injury: a double-blind randomised controlled trial.
- PubMed
- Publication types
- Journal Article, Multicenter Study, Randomized Controlled Trial, Research Support, Non-U.S. Gov't
- PubMed
Topics15
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Acetylcholine Release Inhibitors | Major topic |
| Botulinum Toxins, Type A | Major topic |
| Brain Injuries | Major topic |
| Muscle Spasticity | Major topic |
| Paresis | Major topic |
| Stroke | Major topic |
| Upper Extremity | Major topic |
| Adult | |
| Double-Blind Method | |
| Female | |
| Humans | |
| Injections, Intramuscular | |
| Male | |
| Middle Aged | |
| Treatment Outcome |
Source PubMed
Trials2
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record | Source |
|---|---|---|---|---|
| NCT01313299 | Dysport® Adult Upper Limb Spasticity | Derived from the trial | Yes | ClinicalTrials.gov |
| NCT07744659 | Spinal Cord Stimulation for Poststroke Spasticity | Background | ClinicalTrials.gov |
Comments and corrections1
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers |
|---|---|---|---|
| Comment in | 26318835 | Botulinum toxin A for upper limb spasticity. | https://conductscience.org/library/papers/26318835 |
Source PubMed
Cited by98
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 160 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42931520 | Active Function Improvement with Repeated Injections of Botulinum Toxin A in Upper Limb Spasticity: A Longitudinal Analysis from the ULIS-III Study. | Toxins (Basel) | 2026 | https://conductscience.org/library/papers/42931520 | PubMed |
| 42900276 | Modulating the WNK1-SPAK/OSR1-KCC2 Pathway: Acupuncture's Therapeutic Potential in Mitigating Muscle Hypertonia in Ischemic Stroke Rats. | Neurochem Res | 2026 | https://conductscience.org/library/papers/42900276 | PubMed |
| 42784322 | Goal Attainment and Outcome Evaluation for Upper and Lower Limb Spasticity: A Real-Life Cohort Analysis in a Community-Based Outreach Service. | Toxins (Basel) | 2026 | https://conductscience.org/library/papers/42784322 | PubMed |
| 42662793 | Spastic co-contraction: A misdirected central command. | Clin Neurophysiol Pract | 2026 | https://conductscience.org/library/papers/42662793 | PubMed |
| 42603267 | Shockwave Therapy or Acupoint Stimulation Combined With Physiotherapy for Spasticity and Motor Function in Post-Stroke Recovery: A Randomized Controlled Trial. | Brain Behav | 2026 | https://conductscience.org/library/papers/42603267 | PubMed |
| 42525344 | Spastic Hypertonia Following Middle Cerebral Artery Occlusion in Rats: Assessment of Behavioral, Electrophysiological, and Morphological Parameters in Dynamics. | Bull Exp Biol Med | 2026 | https://conductscience.org/library/papers/42525344 | PubMed |
| 42387889 | Identification of spastic muscles involved in abnormal joint posture in patients with upper motor neuron syndrome: a narrative review. | J Rehabil Med | 2026 | https://conductscience.org/library/papers/42387889 | PubMed |
| 42159955 | A Phase IV, Randomized, Double-Blind, Crossover Study to Compare the Clinical Safety and Efficacy of AbobotulinumtoxinA and OnabotulinumtoxinA in Adult Upper Limb Spasticity. | Adv Ther | 2026 | https://conductscience.org/library/papers/42159955 | PubMed |
| 42047510 | Evolution of goal setting and attainment over repeated cycles of botulinum toxin A for upper limb spasticity in real-life clinical practice: longitudinal analyses from the observational ULIS-III cohort study. | J Rehabil Med | 2026 | https://conductscience.org/library/papers/42047510 | PubMed |
| 41745769 | Cell-Penetrating Botulinum Neurotoxin Type A Proteins Alleviate Skeletal Muscle Hypertrophy with Associated Alterations of Mitochondrial Homeostasis. | Toxins (Basel) | 2026 | https://conductscience.org/library/papers/41745769 | PubMed |
| 41733858 | Electromyographic features for quantitative assessment of lower limb spasticity after stroke: a feasibility study. | Med Biol Eng Comput | 2026 | https://conductscience.org/library/papers/41733858 | PubMed |
| 41591197 | Longitudinal, Multi-Cycle Evaluation of Passive Function Improvement in People with Arm Spasticity Treated with Botulinum Toxin A. | Toxins (Basel) | 2026 | https://conductscience.org/library/papers/41591197 | PubMed |
| 41537530 | Real-world use of botulinum toxin-A for post-stroke spasticity in the Netherlands: a retrospective claims study. | J Rehabil Med | 2026 | https://conductscience.org/library/papers/41537530 | PubMed |
| 41306956 | Tailoring BoNT A treatment and assessment across recovery stages after stroke: a report of four clinical cases. | J Med Life | 2025 | https://conductscience.org/library/papers/41306956 | PubMed |
| 40979203 | Constraint-induced movement therapy reduced shoulder pain and improved function in subacute and chronic stroke: a cohort study. | Front Neurol | 2025 | https://conductscience.org/library/papers/40979203 | PubMed |
| 40881626 | Potential impacts of acupuncture on motor function recovery after ischemic stroke: insights from basic and clinical studies. | Front Cell Neurosci | 2025 | https://conductscience.org/library/papers/40881626 | PubMed |
| 40864061 | Pathways for Diagnosis and Multimodal Management, Including Botulinum Neurotoxin Therapy, in Shoulder Conditions Following Acquired Central Nervous System Lesions. | Toxins (Basel) | 2025 | https://conductscience.org/library/papers/40864061 | PubMed |
| 40678290 | Reliability of the Five Step Assessment and Its Coefficients of Impairment in Spastic Paresis. | Arch Rehabil Res Clin Transl | 2025 | https://conductscience.org/library/papers/40678290 | PubMed |
| 40137890 | Pain Reduction with Repeated Injections of Botulinum Toxin A in Upper Limb Spasticity: A Longitudinal Analysis from the ULIS-III Study. | Toxins (Basel) | 2025 | https://conductscience.org/library/papers/40137890 | PubMed |
| 40021946 | Effects of Electroacupuncture on Syt3 and GluA2 in Rats With Limb Spasms After Intracerebral Hemorrhage. | Brain Behav | 2025 | https://conductscience.org/library/papers/40021946 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/26318836
GET https://conductscience.org/api/papers/v1/26318836/cited_by?page=2